Mobic (Meloxicam)

Meloxicam, the active ingredient in Mobic, is a nonsteroidal anti-inflammatory drug presented as an injectable solution for intramuscular use. It reduces inflammation and pain associated with osteoarthritis, rheumatoid arthritis, acute musculoskeletal pain and post‑operative pain in adult patients.

GNH USA supplies Mobic as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing EU‑sourced products that meet stringent quality standards. The company ensures reliable cold‑chain logistics for injectable medicines and supports regulatory compliance for global markets throughout.

Meloxicam is an NSAID that reduces inflammation by inhibiting cyclooxygenase enzymes, and it is indicated for the following conditions:

- Osteoarthritis: relief of joint pain and stiffness. - Rheumatoid arthritis: reduction of inflammation and joint damage progression. - Acute musculoskeletal pain: rapid alleviation of pain after injury or strain. - Post‑operative pain: control of pain following surgical procedures.

Meloxicam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate intensity. - Injection site reactions: erythema, swelling or pain at the intramuscular site.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: potentially life‑threatening. - Cardiovascular events: increased risk of myocardial infarction or stroke. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When using Meloxicam injectable, clinicians should observe the following precautions to minimize risk.

- Assess renal function: avoid use in patients with severe renal impairment. - Monitor hepatic enzymes: use cautiously in liver disease. - Evaluate cardiovascular risk: consider alternatives in patients with history of myocardial infarction or stroke. - Use with caution in the elderly: increased susceptibility to adverse effects. - Avoid concurrent use with other NSAIDs or anticoagulants: heightened bleeding risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meloxicam can interact with several medicines; notable interactions are grouped below.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective COX‑2 inhibitors: additive toxicity. - ACE inhibitors or ARBs: may reduce renal function.

Moderate Interactions (Monitor Closely): - Diuretics: potential for reduced antihypertensive effect. - Lithium: increased serum lithium levels. - Methotrexate: enhanced toxicity.